team: CHOICE Affiliate Faculty

Rajshree Pandey, PhD, MPH

Dr. Rajshree Pandey specializes in evidence synthesis and comparative effectiveness research methods, including systematic reviews, meta-analyses, indirect treatment comparisons, and health technology assessments. Her research interests include application of these methods to develop impactful global HEOR strategies across therapeutic areas particularly rare diseases, with an emphasis on enhancing efficiency in HEOR using artificial intelligence and addressing health inequities in decision-making and advancing equity-focused research and collaboration. At CHOICE, she contributes to teaching and mentorship in evidence synthesis methods and HTA applications. Dr. Pandey holds a PhD in Health Sciences from the University of Delhi, India, and a Master of Public Health in Epidemiology from the University of Massachusetts Amherst, USA.

Education

• PhD, Pharmaceutical Outcomes Research and Policy, University of Washington
• Master of Health Administration, University of Washington

Education

• PhD, Pharmaceutical Outcomes Research and Policy, University of Washington
• Master of Public Health, Epidemiology, University of Washington

Experience

Education

• PhD in Pharmaceutical Outcomes Research & Policy Studies, University of Washington
• Master of Public Health in Epidemiology, Brown University
• Bachelor of Science in Chemical Engineering and Biomedical Engineering, Carnegie Mellon University

Education

• PhD, Pharmaceutical Outcomes Research and Policy, University of Washington
• Master of Public Health, Epidemiology, Columbia University
• Bachelor of Arts, Biology, Boston University

Education

• PhD in Pharmaceutical Outcomes Research & Policy Studies, University of Washington
• PharmD, University of Southern California
• Master of Science in Biology, University of California, San Diego
• Bachelor of Science in Biology, University of California, San Diego

John Watkins, PharmD, MPH, BCPS managed the formulary process at Premera Blue Cross from 2000-2019. His responsibilities included health technology assessment, formulary process development, formulary reviews, and medical policy review and providing drug information support to medical and case management staff. He is currently Director of Premera’s PGY1 Managed Care Pharmacy Residency program and Student Advanced Pharmacy Practice Experience Coordinator. Along with these responsibilities, he manages the Pharmacy and Therapeutics Committee. John is Affiliate Professor of Pharmacy at the University of Washington. His areas of interest include health policy, health technology assessment and application of evidence-based medicine, personalized medicine, economics and bioethics to formulary and coverage decision making processes.

After graduating from the University of Washington (1979) and working as a community pharmacist, John served as a hospital pharmacy director pharmacology instructor for 7 years in Kathmandu, Nepal. He completed a combined MPH degree in Pharmacy and Health Services at the University of Washington (1993) with a residency at Group Health Cooperative, where he later worked as a clinical and drug information pharmacist. Before coming to Premera, he was a pharmacist at Regence BlueShield. He is board certified in pharmacotherapy, and has a PharmD, also from the University of Washington. He is a member of the AMCP Format Executive Committee, the ISPOR North American HTA Roundtable, HTA Council Working Group – Challenges in the Use of HTA in Pluralistic Healthcare Systems and the  Precision Medicine SIG. He is a member of the Blue Cross Blue Shield Medical Advisory Panel.

John’s interest in formulary systems goes back to Nepal, where he established the first formal P&T committee and developed a combined formulary and drug procurement system serving 30 projects under two separate NGOs. It was there that he first became interested in the problem of managing scarce resources to maximize the value of pharmacotherapy at the patient level.

Dr. Roth specializes in comparative effectiveness research (CER) methods, including: observational study design, decision-analytic modeling, systematic review, meta-analysis, and generalized linear modeling. His research interests involve the application of CER methods to evaluate the benefit-risk tradeoffs and value of pharmaceutical and diagnostic technologies in cancer, with specific focus on pharmacogenomic testing applications, cancer screening strategies, and alternative treatment options in lung, breast, and prostate cancer. He received his MHA from the University of Washington Department of Health Services and a PhD in Pharmaceutical Outcomes Research and Policy from the University of Washington.

Education

• BS, Health Sciences – Department of Health Sciences, Maastricht University, Maastricht, NL
• MSc, Health Science Research – Faculty of Health Sciences, Maastricht University, Maastricht, NL
• PhD, Economic Evaluation of Disease Management Programs
• Faculty of Health Sciences, Maastricht University, Maastricht, NL

Biography

Dr. Steuten graduated with her MSc and PhD from the Department of Health Sciences at Maastricht University in Maastricht, NL. She is an associate member at the Fred Hutchinson Cancer Research Center and an affiliate associate professor in the Pharmaceutical Outcomes Research and Policy Program.

Dr. Steuten’s research expertise is in the fields of health economics and health services research. She specializes in developing and applying quantitative (Bayesian) methods for estimating and comparing the expected health and economic benefits of new approaches and interventions in cancer prevention and treatment, and prioritizing data collection to efficiently build the evidence for such promising new interventions.

Research Interests

Dr. Steuten’s research interests include developing and applying health economic and decision-analytic research methods to accelerate patient access to high value new screening, diagnostic and treatment options against cancer and other diseases.

Teaching Programs Directed

Director of Education: Health Sciences BSc and MSc programs, University of Twente, Enschede, NL

Courses instructed:

• Patient and Care: introduction to Health Sciences, University of Twente, Enschede, NL
• Economic Evaluation in Health Care, University of Twente, Enschede, NL
• Economics of Health and Health Care, University of Twente, Enschede, NL
• Economic Evaluation in Health and Medicine, PHARM 534/HSERV 583, University of Washington, Seattle.

Courses Taught

• Health Technology Assessment for Health Services Innovation, Maastricht University, Maastricht, NL
• Decision Analytic Modelling and Bayesian Value of Information Analysis for Health Care, Maastricht University, Maastricht, NL
• Health Economics – Research Master, Brunel University, London, UK
• Post-Graduate Short Course Health Economics, Brunel University, London, UK
• Medical Technology Assessment, Epidemiology and Statistics, University of Twente, Enschede, NL
• Advanced Modeling: Validation, Calibration, and Extrapolation, PHARM 536, University of Washington, Seattle.

Academic service

• Integrating health economics modelling in the product development cycle of innovative medical devices, Maastricht University, Maastricht, NL
• Transferability of economic evaluations of medical devices, Brunel University, London, UK.